Asian Currencies Under Pressure as Oil Surges and US Dollar Strengthens Amid Geopolitical Tensions Obsession Box Office Shows Remarkable Hold Projected to Drop Only 1 in Second Weekend Pete CrowArmstrongs Slump Could Test Chicago Cubs Outfield Depth and Roster Strategy Warren Buffetts Tiny Purchase in March Berkshire Filing May Reveal the Mystery Investment Retail Traders Outperform Wall Street in Prediction Markets Emerging Analysis Suggests DeepSeek AI Claims Affordable HighPerformance Model Training Without Advanced Chips NWBI Q1 2026 Earnings EPS Surpasses Estimates by 1472 RYAAY Q1 2026 Earnings NarrowerThanExpected Loss as Summer Travel Momentum Builds Tyra Biosciences Inc TYRA Q1 2026 Earnings WiderThanExpected Loss as Clinical Pipeline Progress Continues Merchants Bancorp MBIN Q1 2026 Earnings EPS Beats Expectations by 5 Stock Slightly Lower Silicom Ltd SILC Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares CHCI Q1 2008 Earnings Significant EPS Miss Despite Stock Rally CVD Equipment Corporation CVV Edges Higher Approaches Key Resistance Level Eikon Therapeutics Inc EIKN Slips 224 as Stock Holds Above Key Support Level Daxor Corporation DXR Holds Steady at 1082 as Shares Test Key Support Zone BRBI Slips 164 as Support Test Looms BR Partners ADS Under Pressure Tectonic Therapeutic TECX Slides 174 as Biotech Sector Headwinds Persist Stock Markets Rally as USIran Talks Drive Oil Price Decline KOF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment Occidental Petroleum OXY Drops 163 Key Support and Resistance Levels in Focus Hershey HSY Hovers Near Support as Confectionary Giant Faces Modest Pullback Shake Shack SHAK Surges Over 4 as Shares Test Key Resistance General Motors GM Edges Higher Assessing Key Levels After Modest Gain Antero Midstream AM Gains 165 as Energy Infrastructure Demand Strengthens Red Rock Resorts RRR Holds Steady With Modest Gains as Key Levels Remain in Focus LCI Industries LCII Holds Firm Near Support as Modest Gains Signal Potential Stability NewAmsterdam Pharma NAMS Edges Higher as Shares Test Key Resistance Level